Wall Street’s top analysts are delving into leading tech titans Apple Inc. (NASDAQ:AAPL) and Micron Technology, Inc.
In a research report issued today, Credit Suisse analyst Robert Spingarn reiterated a Neutral rating on shares of Boeing Co (NYSE:BA) with a price …
In a research report released yesterday, Credit Suisse analyst Laurent Grandet initiated coverage on shares of The Coca-Cola Co (NYSE:KO) with a Neutral rating and …
Gilead Sciences, Inc. (NASDAQ:GILD) shares have dipped 22% this past year, as investors are skeptical as to whether the biotech giant’s HCV franchise …
On back of a two-year investigation the European Commission launched into Apple Inc.’s (NASDAQ:AAPL) tax practices, the EU has found the tech giant …
Analyst Christian Bolu of Credit Suisse downgraded LPL Financial Holdings Inc (NASDAQ:LPLA) to Neutral while maintaining a price target of $28.00.
Credit Suisse analyst Erin Wilson weighed in on Aratana Therapeutics (NASDAQ:PETX), after the pet biopharmaceutical company reported second-quarter results, posting EPS of ($0.48), below Wilson’s projection of ($0.
Credit Suisse analyst Jason West spoke with Starbucks Corporation (NASDAQ:SBUX) management on Tuesday and found CFO Scott Maw and Vice President of IR Tom …
Credit Suisse analyst Alethia Young posits, “To acquire or to be acquired, that is the question for Biogen Inc (NASDAQ:BIIB).” Until an answer …
Analyst Alethia Young from Credit Suisse gave her thoughts on Gilead Sciences, Inc. (NASDAQ:GILD) and its place in HCV.
